Major pharmaceutical companies have invested immense resources into developing innovative treatments for cancer. Since 1997 the list of the best selling oncology drugs has evolved significantly.
The high pace in drug development is set to continue and in 2017 the whole oncology pipeline has over 600 molecules in late development stage. (Ver)
Entradas
No hay comentarios:
Publicar un comentario